Atlas Trials

Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma

Clinical trial NCT00734188 · COMPLETED

Trial details

NCT number
NCT00734188
Sponsor
Pain Therapeutics
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Melanoma
Start date
2009-01-01
Primary completion
2010-03-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.